Combined drug toxicity (oxycodone, diazepam, and pregabalin)
AI-generated summary
Melissa May, a 44-year-old woman with chronic pain and opioid dependence, died from combined drug toxicity on 16 December 2013. She had been prescribed oxycodone, diazepam, and pregabalin by doctors at Rich River Health Group, with oxycodone dispensed by Rich River Pharmacy. Despite both doctors and pharmacists believing safeguards existed to prevent early dispensing and drug abuse, critical communication failures allowed Mrs May to access dangerous quantities of medication. A handwritten notation by her doctor not to dispense until 18 December was obliterated before presentation to the pharmacy, likely by Mrs May herself. The pharmacy dispensed all prescriptions without adequate verification, enabling her to obtain sufficient drugs to cause fatal overdose through rapid intravenous injection. The case demonstrates failures in coordination between prescribers and dispensers, inadequate record-keeping, and reliance on undocumented arrangements made years earlier.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes. Report an inaccuracy.
Poor communication between prescribing doctors and dispensing pharmacist
Failure to maintain daily dispensing arrangement for opioid medication despite documented dependence
Dispensing of pregabalin without adequate safeguards despite known synergistic interaction with opioids and benzodiazepines
Inadequate record-keeping by pharmacy regarding safeguarding arrangements
Reliance on undocumented letter from 2008 regarding daily dispensing regime
Acceptance of altered prescription without verification
Dispensing of repeat prescriptions without adequate monitoring of intervals
Patient able to access multiple months of medication simultaneously
Prescription notation obliterated before presentation to pharmacy
Coroner's recommendations
The Royal Australian College of General Practitioners and the Pharmaceutical Board of Australia should collaboratively consider how to incorporate the lessons of this case into future training and the design of future interventions to reduce pharmaceutical drug-related harms.
The Royal Australian College of General Practitioners and the Pharmaceutical Board of Australia should collaboratively consider the need for development of a joint guideline in relation to communication between the professions to ensure the safe prescribing and dispensing of drugs of dependence, including methods of implementing daily dispensing, avoiding early dispensing and the provision of prospective prescriptions.
The Royal Australian College of General Practitioners should consider the need for further education and training or assistance to rural general practitioners dealing with complex patients suffering chronic pain and prescription drug dependence.
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. Some material may have been redacted or restricted by court order or privacy requirements. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction — report an inaccuracy here.